BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 27566003)

  • 1. Role of IQGAP1 in endothelial barrier enhancement caused by OxPAPC.
    Tian Y; Tian X; Gawlak G; Sarich N; Sacks DB; Birukova AA; Birukov KG
    Am J Physiol Lung Cell Mol Physiol; 2016 Oct; 311(4):L800-L809. PubMed ID: 27566003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between adherens junctions and tight junctions via Rap1 promotes barrier protective effects of oxidized phospholipids.
    Birukova AA; Zebda N; Fu P; Poroyko V; Cokic I; Birukov KG
    J Cell Physiol; 2011 Aug; 226(8):2052-62. PubMed ID: 21520057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocyte growth factor-induced Asef-IQGAP1 complex controls cytoskeletal remodeling and endothelial barrier.
    Tian Y; Gawlak G; Shah AS; Higginbotham K; Tian X; Kawasaki Y; Akiyama T; Sacks DB; Birukova AA
    J Biol Chem; 2015 Feb; 290(7):4097-109. PubMed ID: 25492863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of End Binding Protein-1 in endothelial permeability response to barrier-disruptive and barrier-enhancing agonists.
    Tian X; Ohmura T; Shah AS; Son S; Tian Y; Birukova AA
    Cell Signal; 2017 Jan; 29():1-11. PubMed ID: 27667566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Afadin controls p120-catenin-ZO-1 interactions leading to endothelial barrier enhancement by oxidized phospholipids.
    Birukova AA; Fu P; Wu T; Dubrovskyi O; Sarich N; Poroyko V; Birukov KG
    J Cell Physiol; 2012 May; 227(5):1883-90. PubMed ID: 21732359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual role of vinculin in barrier-disruptive and barrier-enhancing endothelial cell responses.
    Birukova AA; Shah AS; Tian Y; Moldobaeva N; Birukov KG
    Cell Signal; 2016 Jun; 28(6):541-51. PubMed ID: 26923917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostaglandin E receptor-4 receptor mediates endothelial barrier-enhancing and anti-inflammatory effects of oxidized phospholipids.
    Oskolkova O; Gawlak G; Tian Y; Ke Y; Sarich N; Son S; Andreasson K; Bochkov VN; Birukova AA; Birukov KG
    FASEB J; 2017 Sep; 31(9):4187-4202. PubMed ID: 28572443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paxillin-beta-catenin interactions are involved in Rac/Cdc42-mediated endothelial barrier-protective response to oxidized phospholipids.
    Birukova AA; Malyukova I; Poroyko V; Birukov KG
    Am J Physiol Lung Cell Mol Physiol; 2007 Jul; 293(1):L199-211. PubMed ID: 17513457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tiam1 and betaPIX mediate Rac-dependent endothelial barrier protective response to oxidized phospholipids.
    Birukova AA; Malyukova I; Mikaelyan A; Fu P; Birukov KG
    J Cell Physiol; 2007 Jun; 211(3):608-17. PubMed ID: 17219408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential regulation of endothelial cell permeability by high and low doses of oxidized 1-palmitoyl-2-arachidonyl-sn-glycero-3-phosphocholine.
    Starosta V; Wu T; Zimman A; Pham D; Tian X; Oskolkova O; Bochkov V; Berliner JA; Birukova AA; Birukov KG
    Am J Respir Cell Mol Biol; 2012 Mar; 46(3):331-41. PubMed ID: 21997484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polar head groups are important for barrier-protective effects of oxidized phospholipids on pulmonary endothelium.
    Birukova AA; Fu P; Chatchavalvanich S; Burdette D; Oskolkova O; Bochkov VN; Birukov KG
    Am J Physiol Lung Cell Mol Physiol; 2007 Apr; 292(4):L924-35. PubMed ID: 17158600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Akt-mediated transactivation of the S1P1 receptor in caveolin-enriched microdomains regulates endothelial barrier enhancement by oxidized phospholipids.
    Singleton PA; Chatchavalvanich S; Fu P; Xing J; Birukova AA; Fortune JA; Klibanov AM; Garcia JG; Birukov KG
    Circ Res; 2009 Apr; 104(8):978-86. PubMed ID: 19286607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p190RhoGAP mediates protective effects of oxidized phospholipids in the models of ventilator-induced lung injury.
    Birukova AA; Zebda N; Cokic I; Fu P; Wu T; Dubrovskyi O; Birukov KG
    Exp Cell Res; 2011 Apr; 317(6):859-72. PubMed ID: 21111731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A role for VEGFR2 activation in endothelial responses caused by barrier disruptive OxPAPC concentrations.
    Birukova AA; Lee S; Starosta V; Wu T; Ho T; Kim J; Berliner JA; Birukov KG
    PLoS One; 2012; 7(1):e30957. PubMed ID: 22303475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IQGAP1 regulates endothelial barrier function via EB1-cortactin cross talk.
    Tian Y; Tian X; Gawlak G; O'Donnell JJ; Sacks DB; Birukova AA
    Mol Cell Biol; 2014 Sep; 34(18):3546-58. PubMed ID: 25022754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signaling pathways involved in OxPAPC-induced pulmonary endothelial barrier protection.
    Birukova AA; Chatchavalvanich S; Oskolkova O; Bochkov VN; Birukov KG
    Microvasc Res; 2007 May; 73(3):173-81. PubMed ID: 17292425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of p190RhoGAP with C-terminal domain of p120-catenin modulates endothelial cytoskeleton and permeability.
    Zebda N; Tian Y; Tian X; Gawlak G; Higginbotham K; Reynolds AB; Birukova AA; Birukov KG
    J Biol Chem; 2013 Jun; 288(25):18290-9. PubMed ID: 23653363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fragmented oxidation products define barrier disruptive endothelial cell response to OxPAPC.
    Birukova AA; Starosta V; Tian X; Higginbotham K; Koroniak L; Berliner JA; Birukov KG
    Transl Res; 2013 Jun; 161(6):495-504. PubMed ID: 23305708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. M3 muscarinic acetylcholine receptor dysfunction inhibits Rac1 activity and disrupts VE-cadherin/β-catenin and actin cytoskeleton interaction.
    Jiao ZY; Wu J; Wen B; Zhao WZ; Du XL
    Biochem Cell Biol; 2014 Apr; 92(2):137-44. PubMed ID: 24697698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross talk between paxillin and Rac is critical for mediation of barrier-protective effects by oxidized phospholipids.
    Birukova AA; Alekseeva E; Cokic I; Turner CE; Birukov KG
    Am J Physiol Lung Cell Mol Physiol; 2008 Oct; 295(4):L593-602. PubMed ID: 18676874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.